Cullinan Oncology (CGEM) Competitor Comparison
We are evaluating the key criteria listed to compare Cullinan Oncology (CGEM) against its competitors in the Biotechnology industry.
Market Capitalization
141 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
270 / 337Free Cashflow
280 / 352Quick Ratio
25 / 357Earnings per Share
264 / 359Dividend yield
0 / 6Total Cash
67 / 358Performance 3 years
128 / 368Performance 5 years
211 / 368Performance 10 years
180 / 368Linearity 3 years
54 / 368Linearity 5 years
199 / 368Linearity 10 years
124 / 367Total Rank
99 / 368Dividend Rank
100 / 368Valuation Rank
69 / 368Piotroski Rank
19 / 368Muliplier Rank
323 / 368Market Capitalization - CGEM ranking 141 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.